Tagged Articles

Sanofi-Aventis 33 articles

Woman joins lawsuit over permanent baldness with Taxotere

Connie Shatswell knew in 2010 when she took chemotherapy to treat her breast cancer that she would temporarily lose her thick, brown hair. She assumed her hair would grow back once her treatment ended. But she never guessed that she’d wind up permanently bald. No one could explain why Connie’s hair never grew back. It wasn’t until she saw a social media post blaming Taxotere chemotherapy as a possible culprit that she realized it was likely the cause. Connie dug deeper and discovered that five years before she took Taxotere, its manufacturer Sanofi-Aventos conducted a study and found that about ... Read More

Disfiguring Taxotere side effect devastating to women

“I find it interesting that TV ads regularly show men and women lamenting their thinning hair and bald spots with various companies offering treatments and potions to restore their manes. Words like ‘embarrassed,’ ‘devastated,’ ‘humiliated’ and ‘depressed’ are used to describe their feelings,” wrote Beth* in a post on the site A Head of our Time. “When cancer patients use these terms with regards to how they feel about their Taxotere-induced hair loss, they have been ridiculed and maligned and told they should be happy to be alive. What’s the difference? If someone who is genetically predisposed to thin hair ... Read More

Women seek centralization of Taxotere hair loss lawsuits

About 350 women suing Sanofi-Aventis and other drug companies for failing to warn about the risk of permanent hair loss from the breast cancer drug Taxotere are calling for the New Jersey Supreme Court to designate the lawsuits as a multicounty litigation under Superior Court Judge James F. Hyland in Middlesex County. Centralizing the lawsuits was recommended because of the large number of cases and the common issues in their claims. Centralized management would conserve judicial resources, provide all those involved with the benefits of coordinated discovery, and minimize duplication, the petition states. The vast majority of the state lawsuits are ... Read More

Pennsylvania woman files Taxotere side effects lawsuit

Kathleen Stajduhar knew in 2010 that the chemotherapy she was receiving to treat breast cancer might cause “temporary” hair loss. What she didn’t expect was for her hair never to grow back. Following treatment with the drug Taxotere, Stajduhar was diagnosed with alopecia, or complete and permanent hair loss. Attempts to remedy the condition proved expensive and unsuccessful. In July 2016 – six years after going bald – Stajduhar saw a television commercial notifying her that Taxotere had been linked to cases of permanent hair loss, that the company failed to warn consumers of this risk, and that patients who ... Read More

Several people file lawsuit alleging Taxotere hair loss

Several people have filed lawsuits against pharmaceutical companies for their hand in the manufacturing of a breast cancer drug that they allege caused them to permanently lose their hair. The lawsuit accueses Sanofi U.S. Services Inc.; Winthrop U.S.; Hospira Worldwide LLC, McKesson Packaging; Sandoz Inc.; Accord Healthcare; and Does Inc., of alleged breach of implied warranty, design defect and product liability. Those suing the companies are Linda Rice, Robert Rice, Antoinette Clark, Vernon R. Clark, Sonia Collins, Earnest Collins, Bianca Conklin, John Conklin, Lynell Daggs, Michael Daggs, Madeleine Dwolakowski, Victor H. Musmanno, Karen Gilyard, David A. Gilyard, Nicole C. Gorman, ... Read More

Chemotherapy maker faces lawsuits over permanent hair loss claims

Hair loss can be expected with many chemotherapies, with regrowth returning after treatment has stopped. But, many women who received the chemotherapy drug Taxotere for at least six months say they have been unable to grow new hair, a condition called alopecia. Taxotere is used to treat a variety of cancers including cancer of the breast, prostate, lung, head and neck, and stomach. It contains the active ingredient Docetaxel and is a member of a family of drugs called taxanes. Taxotere works by slowing cell growth. The medication promises to shorten the length of treatment when combined with other therapies. ... Read More

Taxotere linked to fatal intestinal inflammation

The chemotherapy drug Taxotere has been linked to five fatal cases of neutropenic enterocolitis, an inflammation of the mucosa of the small intestines and colon, the French National Drug and Health Product Safety Agency (ANSM) reports. As a result, the Institut Curie in Paris has stopped using the drug in favor of paclitaxel. Neutropenic enterocolitis is also known as typhlitis, an inflammation that affects the cecum, a part of the large intestine near the appendix. It is associated with a low level of neutrophil granulocytes, the most common form of white blood cells. Taxotere targets and kills these types of ... Read More

Taxotere MDL maintains rapid growth, lawsuits over permanent hair loss

This summer we reported that the Taxotere federal multidistrict litigation had grown from 33 lawsuits to more than 1,000 in just a little more than seven months. Now six months later, the litigation has continued to see dramatic increase. More than another 1,000 suits have been added to the MDL, with a total of 2,304 claims as of Nov. 15, 2017, according to the United States Judicial Panel on Multidistrict Litigation. MDL -2740 Taxotere (Docetaxel) Products Liability Litigation under U.S. District Judge Kurt D. Engelhardt was established in the Eastern District of Louisiana in October of last year. The federal ... Read More

Discovery could lead to better understanding of hair loss

Scientists studying anti-inflammatory immune cells called Tregs discovered that defects in these cells may be responsible for hair loss called alopecia areata. Alopecia areata is a common autoimmune skin disease where the immune system attacks hair follicles, causing the hair to fall out in round patches on the scalp. There is often hair loss on the face and sometimes other areas of the body. There is no cure for alopecia areata. When the researchers temporarily removed the Tregs from the skin of laboratory mice, they discovered that patches of hair that had been shaved were not regrowing. Curious at this ... Read More

Drug companies race to get FDA approval of alopecia treatment

Alopecia is the medical term for hair loss. Hair loss for both men and women comes with not only the obvious physical repercussions, but also often emotional consequences as well, with sufferers wrestling with issues of identity and self-confidence as their appearance is sometimes dramatically altered. The most common type of alopecia, which is very well known is hereditary. Called androgenetic alopecia, also known as pattern hair loss, it affects 80 million men and women in the United States. Another form of alopecia that is very familiar is drug-induced, often by chemotherapy. Under normal circumstances, this is a temporary hair ... Read More